Black women have twice the risk of being diagnosed with uterine clear cell carcinoma compared with other races, according to a new study of nearly half a million U.S. women diagnosed with uterine cancer from 2004 to 2016.
Uterine clear-cell carcinoma (above) is a rare form of endometrial cancer that’s aggressive, has a high recurrence rate, and has a 5-year survival rate of 58 percent. Fortunately, only about one in 200,000 Black women are diagnosed with this cancer. The greater incidence in Black women is attributed to genetics and certain gene mutations.
See the full text of the scientific paper “Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?” by Stephanie Chow et al.
